James Kobielus

In the post-pandemic “new normal,” AI-driven intelligence will enable enterprise HR personnel to dynamically assess the operational costs, security risks, and productivity trade-offs associated with having employees work out of shared offices.

The post-pandemic “new normal” will see a proliferation of IoT-connected biosensors both in their traditional locations and in entirely new locations, such as government, enterprise, and consumer environments.

Going forward, many tech vendors will package social distancing tools in new ways to make these capabilities ubiquitous while tailoring them to vertical industry requirements.

The most important investments that IBM is making in quantum AI is to build out its developer and partner ecosystem and to provide them with sophisticated tools, libraries, and cloud services.

In the growing AIOps segment, IBM’s strong suit will be its world-class portfolio of AI, advanced analytics, and data management offerings.

With the onset of the COVID-19 pandemic, IT vendors like IBM need to keep customers focused on the business continuity implications of pandemic-response tactics.